BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-28 00:00 |
Q1 statement / Q1 financial report 2023/2024
|
English | PDF • 156.0 KB | ||
| 2024-02-01 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023
|
German | ZIP • 956.8 KB | ||
| 2024-02-01 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.10.2022 bis zum 30.09.2023
|
German | ZIP • 441.3 KB | ||
| 2024-01-26 00:00 |
Annual financial report 2022/2023
|
English | PDF • 2.3 MB | ||
| 2024-01-24 15:05 |
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 12.03.…
|
German | HTML • 229.8 KB | ||
| 2024-01-17 07:30 |
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy
|
English | HTML • 62.3 KB | ||
| 2024-01-10 10:01 | English | HTML • 4.6 KB | |||
| 2024-01-10 00:00 |
Hinweis auf Konzernabschluss vom 01.10.2022 bis zum 30.09.2023
|
German | HTML • 5.7 KB | ||
| 2024-01-10 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.10.2022 bis zum 30.09.2023
|
German | HTML • 5.7 KB | ||
| 2023-11-20 09:44 |
Akribion Genomics receives the Hessian Founder Award for its innovative approac…
|
English | HTML • 16.5 KB | ||
| 2023-10-30 12:46 | German | HTML • 13.1 KB | |||
| 2023-09-28 10:30 |
BRAIN Biotech AG: BRAIN Biotech AG s Akribion Genomics team wins first prize at…
|
English | HTML • 15.3 KB | ||
| 2023-09-14 10:30 |
BRAIN Biotech AG: BRAIN Biotech AGs Akribion Genomics technology receives paten…
|
English | HTML • 24.2 KB | ||
| 2023-09-12 15:45 |
BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Awar…
|
English | HTML • 16.2 KB | ||
| 2023-08-30 07:30 |
BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments …
|
English | HTML • 20.7 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
